Texas Heart Institute Salutes Aryn Knight on Her Election to the Society of Clinical Research Associates’ National Board of Directors

Houston, TX – The Texas Heart Institute is pleased to share with the community that Aryn Knight, Administrative Director of its Center for Clinical Research, has been elected to the Society of Clinical Research Associates (SOCRA) National Board of Directors for a three-year term.


Knight is a Certified Clinical Research Professional (CCRP) with more than 20 years of direct experience in clinical research in academia and hospital environments. Her research experience has included research compliance, research coordination, protocol development, grant writing and submissions, budget development, IRB submission and all regulatory maintenance, Sub-Investigator, research operation development and management, supervision and training of other research coordinators, and development of clinical research programs. Additionally, she possesses direct clinical research experience within the specialties of cardiology, pediatrics, gastroenterology, neonatal ICU, psychiatry, psychology, and neurology.


“I would like to thank the SOCRA Houston Galveston Chapter for its ardent support over the last eight years while I served in the role of Chapter Chair. Additionally, I want to thank the Texas Medical Center clinical research community for its commitment to building a strong clinical research community for all of the professionals within its ranks. Finally, I want to thank my professional family at the Texas Heart Institute. The constant reassurance I receive from THI helps me continue to fight to advance clinical research on a daily basis. I am so lucky to have such generous support,” Knight emphasized.


The Society of Clinical Research Associates (SOCRA) is a non-profit, charitable and educational membership organization committed to providing education, certification, and networking opportunities to all persons involved in clinical research activities. SOCRA, the premier educational organization for oncology site coordinators, has now emerged as a leading educational organization for clinical researchers in all therapeutic areas, supporting industry, government, and academia.


“As a SOCRA Board Member, I will diligently work to further the Society’s mission by dedicating my time and talent to represent members’ needs and interests through the development of educational programming and networking experiences, as well as the expansion of our community relationships,” Knight concluded.